Loss of p73 induction in a cisplatin-resistant bladder cancer cell line

Molecular Urology

Volumn 5, Issue 1, 2001, Pages 25-30

  Ono, Y ^a   Nonomura, N ^a   Harada, Y ^a   Fukui, T ^a   Tokizane, T ^a   Sato, E ^a   Nakayama, M ^a   Nishimura, K ^a   Takahara, S ^a   Okuyama, A ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CISPLATIN; PROTEIN P53; PROTEIN P73;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE INDUCTION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0035088436     PISSN: 10915362     EISSN: None     Source Type: Journal    
DOI: 10.1089/109153601750124267     Document Type: Article

References (24)

1. Identification of p53 gene mutations in bladder cancers and urine samples
2. Current recommendations for the management of bladder cancer: Drug therapy
3. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
4. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
5. P73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
6. Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis
7. Cisplatin-resistant bladder carcinoma cells: Enhanced expression of metallothioneins
8. Isolation of a novel GPI-anchored gene specifically regulated by p53: Correlation between its expression and anti-cancer drug sensitivity
9. Cisplatin and Adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line
10. Loss of DNA mismatch repair in acquired resistance to cisplatin
11. p53 mutations in bladder carcinoma cell lines
12. 1 arrest and apoptosis
13. Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro
14. Overexpression of metallothionein confers resistance to anticancer drugs
15. Multidrug resistance: Molecular mechanisms and clinical relevance
16. Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient ceils
17. Caspases: The executioners of apoptosis
18. Caspases: Intracellular signaling by proteolysis
19. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
20. An induced proximity model for caspase-8 activation
21. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
22. Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance
23. Apoptosis by death factor
24. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis